Tafamidis

CAS 594839-88-0 13 FDA-DMF suppliersSmall Molecule

Overview

Tafamidis is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2103837).

API suppliers (13)

Suppliers of Tafamidis backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • Dr. Reddy's Laboratories Ltd.India1 active DMF
  • SS PHARMA LLCIndia1 active DMF
  • MAHIMA LIFE SCIENCES PRIVATE LTDIndia1 active DMF
  • ALIVUS LIFE SCIENCES LTDIndia1 active DMF
  • Cipla USA, Inc.USA1 active DMF
  • Taiji Biopharmaceuticals Pvt. Ltd.India1 active DMF
  • TAPI NL BVNetherlands1 active DMF
  • APITORIA PHARMA PRIVATE LTDIndia1 active DMF
  • Sun Pharmaceutical Industries LimitedIndia1 active DMF
  • MSN Laboratories Private LimitedIndia1 active DMF
  • SAPTAGIR LABORATORIES PRIVATE LTDIndia1 active DMF
  • HUNAN DONGTING PHARMACEUTICAL CO LTDChina1 active DMF
  • FARMAK ASUkraine

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Tafamidis expires 31 Aug 2035 and exclusivity 3 May 2026. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name
2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid
Canonical SMILES
C1=CC2=C(C=C1C(=O)O)OC(=N2)C3=CC(=CC(=C3)Cl)Cl
InChIKey
TXEIIPDJKFWEEC-UHFFFAOYSA-N

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo